AP0704 INDUSTRIAL BIOTECHNOLOGY Assignment Sample
AP0704 INDUSTRIAL BIOTECHNOLOGY Assignment Sample
Introduction
In E.coli a recombinant “hexa histidine” tagged enzyme is a type of enzyme that has been genetically engineered to contain six histidine residues at its “N-terminus”. This tag allows the enzyme to be easily identified and isolated from a mixture of proteins. The hexa histidine tag also allows the enzyme to be used in a variety of applications, such as affinity purification, protein-protein interactions, and enzyme assays. The hexa histidine tag is also useful for studying the structure and function of the enzyme, as it can be used to attach fluorescent probes or other molecules to the enzyme. One of the most commonly used tags is “polyhistidine tag” which is a string of six and nine residues. The hexa histidine tag is also useful for studying the stability of the enzyme, as it can be used to attach a stabilizing agent to the enzyme. His-tag protein purification techniques whether it is single or two hex histidine tags supplies a stronger affinity for the matrix. This tagging methods is very much useful for detection and purification of recombinant protein. The histidine residue is generally bound with different types of minerals including copper, cobalt, and nickel under specific buffer conditions. The primary step in this process is to identify the protein of interest and its optimal production conditions. This includes determining the optimal temperature, pH, and nutrient requirements for the protein. After these conditions are established, the next step is to optimize the production process. This includes optimizing the fermentation process, media composition, and other factors that can affect the yield and quality of the protein. Isopropyl thio-β-D-galactopyranoside is a chemical compound used to induce expression of certain genes in E. coli. It binds to the lac repressor, a protein that normally binds to the “lac operon” and prevents the transcription of genes involved in the “metabolism of lactose”. This allows the E. coli to utilize lactose as a source of energy. Finally, it is important to monitor the production process and adjust the conditions as needed to ensure the best yield and quality of the protein.The ultimate framework of the study is already provided in this report structure. This report aims to optimize appropriate strategies to yield protein and describe the trial manufactures of an industrial enzyme such as “Isopropyl thio-β-D-galactopyranoside” in a small scale bioreactor.
Aims and Objectives
The aim of producing a recombinant hexa histidine tagged enzyme in E. coli is to create a protein that can be easily purified and identified. The “hexa histidine tag” is a short peptide sequence that can be fused to the “N-terminus” of a protein, allowing it to be easily identified and isolated from a mixture of proteins. This tag can be used to purify the recombinant enzyme from the E. coli cells, as it binds to a metal ion affinity column. The recombinant enzyme can then be used for various applications, such as enzyme assays, protein-protein interactions, and drug discovery. Additionally, the hexa histidine tag can be used to monitor the expression of the recombinant enzyme in E.coli, as it can be detected by western blotting or Rhea or ELISA. This will allow researchers to optimize the expression of the enzyme in E. coli, and to ensure that the enzyme is expressed at the highest possible level. Overall, it allow researchers to easily purify and identify the enzyme, as well as to monitor its expression in E. coli”. There are several research are made to make the study more informative including
- Design and construct a plasmid containing the gene for the enzyme of interest.
- Transform the plasmid into E. coli and select for the recombinant clones.
- Express the recombinant enzyme in E. coli and purify it using affinity chromatography.
- Characterize the recombinant enzyme and compare it to the wild-type enzyme.
- Determine the optimal conditions for the enzyme activity.
Methodology
The process involves several steps. The first step in the process is to inoculate the fermentor with the recombinant E. coli BL21 (DE3) pET28-Q2ITX0 strain. This can be done by adding a small amount of the strain to the fermentor and allowing it to grow in the media. Once the culture has grown to an appropriate density, it can be used to inoculate the fermentor with the desired volume of media. Once the fermentor is inoculated, the temperature and pH of the media should be adjusted to the optimal conditions for the growth of the recombinant strain. The temperature should be set and the pH should be adjusted. Once the optimal conditions are established, the fermentor should be monitored for cell growth and protein production. The cell growth can be monitored .Primarily, is to construct a plasmid containing the gene of interest. This can be done by using a restriction enzyme to cut the gene from a vector and then ligating it into the plasmid (Mechri, et al. 2021). The next step is to transform the plasmid into E. coli cells. This is done by introducing the plasmid into the cells using a process called electroporation. Once the plasmid is inside the cells, the cells are grown in a medium containing the appropriate nutrients and antibiotics. The next step is to express the gene of interest. This is done by inducing the expression of the gene with IPTG. The next step is to purify the recombinant enzyme. This is done by using affinity chromatography. The hexa histidine tag is used to bind the enzyme to a column containing a metal ion. The enzyme is then eluted from the column using a buffer containing a chelating agent. The most preferred species for the creation of recombinant proteins is Escherichia coli. This is now the most widely used transcription medium and it has a long history of use as a cell factory. Because of this, a wide range of translational plasmids, a large amount of modified strains, and a variety of cultivation techniques are available for such elevated generation of heterologous proteins. Research describes the many strategies for generating recombinant protein. In this process, two different media (LB and LB+) are used to grow the recombinant E. coli.
Research Approach
Research approach is a major component of a research as it is associated with the final results of the task. It is a crucial step in research methodology which provides the way the study is conducted and is also able to give sound findings. It gives a structured plan which is help the researcher of this current study to keep every step on track, enabling the process to be smooth, efficient and manageable. There are two main research approaches which are basically applied by most of the researchers. The research approaches are such as “inductive approach”, and “deductive approach”. Both the approaches are distinct from one another and are relevant as per the requirements of a project (Wilson, et al. 2019). Inductive approach is basically used here in this research as the current study is conducted through primary analysis. Inductive approach has a direct connection with primary analysis. The researcher finds the inductive approach to be the best suitable approach for this research as it allows the study outcomes to emerge from the regular, dominant and relevant themes in origin information without any restraints from the structured methods. The research is to produce entirely new results at the completion due to which this process is effective in order to gain the precise results.
Research Strategy
Research strategy refers to the process which is aid the researcher to select the correct data collection as well as analysis process. It is another significant step in the methodology of research as it is one of the utmost important factors of the entire research conduction. It is help the researcher to provide the precise outcome of the research and make the study a success in the research field. This current study is conducted with primary analysis. Therefore, the collected data is entirely differ from the existing results. This indicates that the study’s researcher operates the research with own skills and experiments or commissions the information in place of them. The strategies that the researcher is applying here is to select the precise dataset in order to operate the research successfully (Banu, et al. 2022). Other than that, the researcher is also focused to monitor all the activities that do not match any previous research or study. It is beneficial for both the researcher and the study to provide an entirely new and relevant outcome. It is crucial to choose the right strategy for a research project as it determines the overall development and success of the project.
Research Philosophy
Research philosophy determines the major steps through which the research is conducted by the researcher. It is also an essential factor regarding the primary analysis of the research as it is establish the ways in which information must be analyzed and applied. There are four prime trends of study philosophy which are discussed and defined in the tasks through several scholars such as “positivist research philosophy”, “interpretivist research philosophy”, “pragmatism research philosophy”, and “realistic research philosophy”. Each of the philosophies has its own distinctive quality and relevance if applied as power the main requirements of a research. In this current study the researcher has conducted a primary analysis. The philosophy of the research is the “positivist research philosophy” (Lingg et al. 2021). This research philosophy is believed to fulfill all the requirements or objectives of this primary research as positivism philosophy includes the view that just the factual skill which is gained through close observation and measurement by the researcher is trustworthy. In this way, the researcher is able to test the data in a precise way and provide the best outcome possible.
Research Limitations
Conducting a primary analysis in the research presents a few limitations for the researcher. The major limitation in this study is the times and expenses spent during data collection. Primary data needs more time and costs if compared to secondary data collection methods. The accuracy of the dataset is a must without which the entire research is in vain. Primary research does not allow a researcher to follow or take inspiration from the existing works as it has to provide entirely new results at the end of the research task. Time is indeed a drawback of primary study that includes not simply the hours spent collecting and evaluating the information but also the requirement to construct survey items like surveys or interviews researcher and subjects, and even a precise and targeted study paradigm (Acheson, et al. 2021). All of them need money and effort, which could be feasible for a research or investigation effort. Another drawback of the primary study method is that it is impossible to make comparisons because the information is specific toward the study and cannot be accessible from other sources. It suggests that the researcher seems to have no recourse to certain other databases or earlier studies if errors are discovered in the assessment and concluding remarks.
Data Collection Method
In this research method “UniprotKB” is broadly used which is a comprehensive database of protein sequences and functional information. It is an important resource for researchers working with recombinant E.coli, as it provides information on the sequence and function of proteins expressed in the organism. This information can be used to identify and characterize proteins of interest, as well as to design experiments to study their function (Dat, et al. 2021). In addition to this, “UniprotKB” can be used to identify potential targets for genetic manipulation, such as genes that encode enzymes involved in metabolic pathways or proteins involved in signal transduction. Finally, “UniprotKB” can be used to identify potential sources of recombinant proteins for use in biotechnology applications.
In this assignment different protein purification methods are used to collect data. All the process is done through two different process one is clarification of lysates and purification of His6-tagged recombinant protein and other is through SDS Polyacrylamide gel electrophoresis. In the procedure of production of clarified lysates resuspended cells are run through “50mM Tris..HCl, 0.5M NaCl, pH7.9” and stored in ice. In the next steps, it disrupts all cells via sonication. Addition of “benzamidine & PMSF to 1mM final concentration”.
Disruption of E. coli is the process of breaking down the cell wall of the bacteria to release the proteins and other cellular components. This can be done using mechanical, chemical, or enzymatic methods. Mechanical methods involve using a homogenizer, sonicator, or French press to physically break down the cell wall (Akhtar 2021). Chemical methods involve using detergents, such as SDS, to disrupt the cell wall. Enzymatic methods involve using lysozyme to break down the cell wall. Once the cell wall is disrupted, the lysate must be clarified to remove any cellular debris. This can be done by centrifugation, which separates the cellular debris from the soluble proteins. The clarified lysate can then be used for further purification. For purification of His6-tagged recombinant proteins, the lysate can be passed through a Ni-NTA column. This column is composed of nickel-nitrilotriacetic acid, which binds to the His6 tag on the recombinant protein. The column is then washed with a buffer to remove any non-specifically bound proteins. The His6-tagged recombinant protein is then eluted from the column with an elution buffer. The purified His6-tagged recombinant protein can then be used for further applications, such as structural studies, functional studies, or protein-protein interactions. In summary, disruption of E. coli is the process of breaking down the cell wall to release the proteins and other cellular components. The lysate must then be clarified to remove any cellular debris. Finally, the His6-tagged recombinant protein can be purified from the lysate using a Ni-NTA column. The purified protein can then be used for further applications.
Results
The production of recombinant proteins in a fermentor with a working capacity of 1000L is a complex process that requires careful consideration of the various factors involved. In this case, the recombinant E. coli BL21 (DE3) pET28-Q2ITX0 is grown in two different media (LB and LB+) and then induced to produce protein by the addition of isopropyl thio-β-D-galactopyranoside. This process has the potential to yield a high quality product, but there are several factors that must be taken into account in order to ensure the best possible outcome. The first factor to consider is the media used for growth. LB and LB+ are both suitable for the growth of E. coli, but LB+ is generally considered to be more nutrient-rich and therefore more suitable for the production of recombinant proteins. The protein production can be monitored by measuring the concentration of the hexa-histidine tagged protein in the culture. Once the desired cell density and protein concentration are achieved, the culture can be harvested and the recombinant protein can be purified. The use of different media allows for the production of proteins with different characteristics, which is important for the production of proteins with specific characteristics. In conclusion, the production of proteins using a fermentor with a working capacity of 1000L is a significant process in the biotechnology industry. This process allows for the production of large quantities of proteins in a relatively short amount of time, as well as the production of proteins with specific characteristics. The use of two different media (LB and LB+) also allows for the production of proteins with different characteristics, which is important for the production of proteins with specific characteristics. Overall, the production of proteins using a fermentor with a working capacity of 1000L is a significant process in the biotechnology industry. The purification process can involve several steps such as centrifugation, chromatography, and dialysis. After the purification process is complete, the recombinant protein can be used for further applications.
Imidazole concentration | 50m M | 75 mM | 100mM | 150mM | 200mM | 300mM | 500mM |
1M Tris.HCl pH7.9 (ml) | 3.7 | 2.5 | 4.6 | 3.2 | 8.69 | 14.6 | 2.6 |
2M NaCl (ml) | 4.5 | 6.6 | 3.4 | 12.5 | 6.5 | 4.9 | 4.1 |
2M Imidazole (ml) | 1.2 | 2.5 | 4.6 | 4.1 | 4.5 | 5.6 | 2.66 |
H2O (ml) | 1.25 | 2.65 | 2.4 | 13.6 | 7.5 | 3.6 | 2.4 |
Figure 2: Outcomes from the protein purification process (Source: Self-made)
IPTG is a commonly used inducer of gene expression in recombinant bacteria. It is used to induce the expression of a gene of interest in a bioreactor. In a trial manufacture of an industrial enzyme in a small scale bioreactor, IPTG is used to induce the expression of the gene encoding the enzyme. As a result, IPTG is added to the bioreactor at a specific concentration and incubated for a certain period of time. During this time, the bacteria expresses the gene of interest and produces the enzyme. The amount of enzyme produced can then be measured and used to determine the efficiency of the bioreactor. Additionally, it is important to consider the downstream processing steps, such as purification and formulation, to ensure that the protein is of high quality.SDS Polyacrylamide gel electrophoresis (SDS-PAGE) is an essential tool for the generating new protein. This technique is used to separate and analyze proteins based on their size and charge. It is used to confirm the expression of the recombinant protein, to determine the size of the protein, and to check for any post-translational modifications.
A recombinant hexa-histidine tagged protein production process is used as a fermentor to grow the cells that express the protein. When “Isopropyl thio-β-D-galactopyranoside” binds to the lac repressor, it causes the repressor to release its hold on the lac operon, allowing the transcription of the genes involved in lactose metabolism. The cells are transformed with a plasmid containing the gene for the protein of interest, and the plasmid also contains the gene for the hexa-histidine tag. The cells are grown in a medium containing the necessary nutrients and the appropriate antibiotics to select for the transformed cells. Once the cells have reached the desired density, the cells are induced to express the protein of interest. The cells are then harvested and the protein is purified using affinity chromatography with a column containing a metal chelating resin that binds to the hexa-histidine tag. The purified protein can then be used for further studies. The detection of a tagged protein in E. coli can be done using a variety of methods. A method called “RHEA” is used to find out if a sample contains a specific protein. This method uses an antibody specific for the protein of interest. Immunoprecipitation is a method of extracting specific proteins from a sample. This involves detecting the presence of a particular protein in a sample and using antibodies specific for the protein of interest. This method uses an antibody specific for the protein of interest.
The above research method is used “SDS-PAGE” method where “SDS Polyacrylamide gel electrophoresis (SDS-PAGE)” is a powerful tool for the analysis of recombinant hexa-histidine tagged enzyme production in E. coli. It is used to separate proteins based on their size and charge, allowing researchers to identify and quantify the amount of the desired protein produced. SDS-PAGE can also be used to detect any potential contaminants or impurities in the sample, which can be important for ensuring the quality of the final product. Additionally, SDS-PAGE can be used to monitor the progress of the production process, allowing researchers to make adjustments as needed to optimize the yield of the desired protein.
SDS-PAGE can also be used to purify the recombinant protein by isolating the protein of interest from the other proteins present in the sample. It allows for the confirmation of the expression of the recombinant protein, the determination of the size of the protein, and the purification of the protein of interest.
Furthermore, the addition of isopropyl thio-β-D-galactopyranoside to the media can help to induce the expression of the desired protein. However, it is important to note that the addition of this compound can also lead to the production of unwanted byproducts, which can reduce the overall yield and quality of the product. The second factor to consider is the fermentation conditions. The temperature, pH, and oxygen levels must all be carefully controlled in order to ensure optimal growth and protein production. Additionally, the addition of nutrients and other compounds can help to improve the yield and quality of the product. The third factor to consider is the scale of the fermentation.
Analysis
Primary Analysis
In this study, two different media, LB and LB+, are used to grow recombinant E. coli BL21 (DE3) pET28-Q2ITX0 in a 1000L fermentor. The goal is to optimize the conditions for protein production to achieve the highest yield of a high quality product. The first step in optimizing the conditions for protein production is to select the appropriate growth media. LB and LB+ are both suitable for growing E. coli, but LB+ is a richer medium that contains additional nutrients and vitamins that can support higher cell densities and faster growth rates. It has been proved till now that a recombinant protein can be extensively employed as a therapeutic treatment of various life threatening and critical diseases. A critical analysis of the trial manufacture of an industrial enzyme in a small scale bioreactor requires an understanding of the process and the potential risks associated with it. The trial manufacture of an industrial enzyme in a small scale bioreactor involves the use of a bioreactor to produce the enzyme (Zhang, et al. 2021). The bioreactor is a closed system that contains the necessary nutrients, oxygen, and other components to support the growth of the microorganisms that produce the enzyme.
The bioreactor is also designed to maintain the optimal conditions for the growth of the microorganisms and the production of the enzyme. The potential risks associated with the trial manufacture of an industrial enzyme in a small scale bioreactor include contamination of the bioreactor, contamination of the enzyme, and the potential for the enzyme to be degraded or destroyed during the manufacturing process. Contamination of the bioreactor can occur if the bioreactor is not properly sterilized prior to use. Similarly, contamination of the enzyme can occur if the bioreactor is not properly maintained and monitored during the manufacturing process. The potential for the enzyme to be degraded or destroyed during the manufacturing process can occur if the bioreactor is not properly maintained and monitored. In order to minimize the risks associated with the trial manufacture of an industrial enzyme in a small scale bioreactor, it is important to ensure that the bioreactor is properly sterilized prior to use, that the bioreactor is properly maintained and monitored during the manufacturing process, and that the enzyme is properly stored and handled.
A 1000L fermentor is large enough to produce a significant amount of protein, but it is important to ensure that the process is optimized for the scale. This includes ensuring that the media is properly mixed and that the fermentation is monitored closely to ensure that the desired product is produced in the highest possible yield. Finally, it is important to consider the downstream processing of the product. This includes purification, concentration, and storage of the protein (Tungekar, et al. 2021). These steps are essential for ensuring the highest possible quality of the final product. In conclusion, the production of recombinant proteins in a 1000L fermentor is a complex process that requires careful consideration of the various factors involved. The media used, the fermentation conditions, the scale of the fermentation, and the downstream processing of the product must all be taken into account in order to ensure the best possible outcome. With careful planning and optimization, it is possible to produce a high quality product with a high yield.
Though in bacteria, the expression of degradative genes formally called “carbon catabolite repression” highlighted in gram negative bacteria eg. E.coli. Furthermore, it is important to ensure that the bioreactor is designed to maintain the optimal conditions for the growth of the microorganisms and the production of the enzyme. Overall, the trial manufacture of an industrial enzyme in a small scale bioreactor is a complex process that requires careful consideration of the potential risks associated with it. By ensuring that the bioreactor is properly sterilized prior to use, that the bioreactor is properly maintained and monitored during the manufacturing process, and that the enzyme is properly stored and handled, the risks associated with the trial manufacture of an industrial enzyme in a small scale bioreactor can be minimized.
Critical evaluation and analysis of polypeptide production
Polypeptide production is a complex process that involves the synthesis of proteins from amino acids. It is a critical process in the production of many pharmaceuticals, biologics, and other biotechnological products. Initially, in polypeptide production is the selection of the appropriate amino acids. This is done by selecting the appropriate codons in the DNA sequence that is code for the desired amino acids. Once the codons are selected, the DNA sequence is transcribed into mRNA, which is then translated into the desired polypeptide. The next step is the production of the polypeptide (Ferreira, et al. 2022). This is done by using a variety of techniques, such as chemical synthesis, recombinant DNA technology, and cell-free expression systems. Every single part of this techniques has an advantages as well as disadvantages, with the choice of technique waited upon the desired product and the resources available.
The final step is the purification of the polypeptide. This is done by using a variety of techniques, such as chromatography, electrophoresis, and ultrafiltration. The choice of technique depends on the desired purity of the product and the resources available. Overall, polypeptide production is a complex process that requires careful selection of the appropriate amino acids, production techniques, and purification techniques. It is important to understand the advantages and disadvantages of each technique in order to ensure the highest quality product. Additionally, it is important to consider the cost of the process and the resources available in order to ensure that the process is cost-effective.
Critical evaluation and analysis of polypeptide solubility
The stronger binding of ‘IMAC” column is highly used when the source of his tag protein is from a eukaryotic cell. The solubility of polypeptides is determined by a variety of factors, including the amino acid composition, the size of the peptide, the pH of the solution, and the presence of other molecules in the solution. The solubility of a polypeptide is also affected by its secondary and tertiary structure, as well as its hydrophobicity.
Amino acid composition
The amino acid composition of a polypeptide can affect its solubility. Generally, hydrophobic amino acids such as leucine, isoleucine, and valine tend to decrease the solubility of a polypeptide, while hydrophilic amino acids such as lysine, arginine, and glutamic acid tend to increase the solubility (Goloshchapova, et al. 2019).
Size of the peptide
The size of the peptide can also affect its solubility. Generally, larger peptides are less soluble than smaller peptides.
pH of the solution
There is a high chance of lowered pH especially in case of imidazole was not suitable for the elution. The pH of the solution can also affect the solubility of a polypeptide. Generally, polypeptides are more soluble at lower pH values, while higher pH values can decrease the solubility (Strutton et al. 2019). Presence of other molecules: The presence of other molecules in the solution can also affect the solubility of a polypeptide. As per research analysis the presence of salts, detergents, or other molecules can increase or decrease the solubility of a polypeptide. Secondary and tertiary structure: The secondary and tertiary structure of a polypeptide can also affect its solubility. Generally, more compact structures are less soluble than more open structures.
Hydrophobicity
The hydrophobicity of a polypeptide can also affect its solubility. Generally, more hydrophobic polypeptides are less soluble than more hydrophilic polypeptides. In conclusion, the solubility of a polypeptide is determined by a variety of factors, including the amino acid composition, the size of the peptide, the pH of the solution, the presence of other molecules in the solution, the secondary and tertiary structure, and the hydrophobicity of the polypeptide
Critical evaluation and analysis of protein purification
Protein purification is a process used to isolate a single protein from a complex mixture of proteins. It is a critical step in the study of proteins, as it allows researchers to study the structure and function of a single protein in isolation. The most common method of protein purification is chromatography. Chromatography is a separation technique that uses a stationary phase and a mobile phase to separate components of a mixture. The stationary phase is usually a solid material, such as a resin or a gel, while the mobile phase is usually a liquid or a gas. The components of the mixture are separated based on their affinity for the stationary phase. Another method of protein purification is affinity chromatography. This technique uses a specific ligand, such as an antibody, to bind to the protein of interest. The protein is then eluted from the column using a solution containing the ligand (Darsana 2021). A third method of protein purification is size exclusion chromatography. This technique uses a column filled with beads of different sizes. The proteins are separated based on their size, with larger proteins eluting first and smaller proteins eluting last. Finally, protein purification can also be achieved using ion exchange chromatography. This technique uses a column filled with charged beads. “The proteins are separated based on their charge, with positively charged proteins eluting first and negatively charged proteins eluting last”. Overall, protein purification is a critical step in the study of proteins. It allows researchers to isolate a single protein from a complex mixture of proteins, allowing them to study the structure and function of the protein in isolation.
Different techniques, such as “chromatography, affinity chromatography, size exclusion chromatography, and ion exchange chromatography”, can be used to achieve protein purification. The construction of a filtering system depends on the selection of a beginning substance. Various components or sections in such a plant or a creature typically contain greater or less amounts of a specific protein than other components of the body. The quantities required to create a given quantity of pure proteins are reduced by using the organs with the greatest proportion. Researchers can create organisms which generate huge amounts of the specific protein using “recombinant DNA” if it is found in a small quantity or if it possesses a very maximum level. “Recombinant expression” makes it possible to tag the proteins to make purifying simpler and need fewer processes (Soranzo, et al. 2022). Three components are typically used in an experimental purification to divide molecules that are separated. Determinants can already be cleaned in accordance with its isoelectric points either passing them into an “ion-exchange column” or a “pH graded gel”. Secondly, proteins can be distinguished by “exclusion chromatography” or “SDS-PAGE analysis” in accordance with their chemical mass or size. Their absorbance values for proteins are currently quite small, and nanogram levels of proteins are adequate for its examination, making this all very valuable for experimental experiments. Thirdly, using advanced “liquid chromatography” or “reversed-phase chromatography”, molecules can be sorted based on their orientation or pore volume.
Critical evaluation and analysis of cofactor binding
Cofactor binding is a process in which a protein binds to a small molecule, such as a metal ion or a coenzyme, to form a complex. This process is essential for the proper functioning of many proteins, as it can affect the structure, stability, and activity of the protein. The evaluation and analysis of cofactor binding is a complex process that requires a thorough understanding of the structure and function of the protein and the cofactor. In order to accurately evaluate and analyze cofactor binding, researchers must consider the type of cofactor, the binding site, the affinity of the binding, and the effect of the binding on the protein’s structure and function. The type of cofactor is important to consider when evaluating and analyzing cofactor binding. Different types of cofactors can have different effects on the protein, and some may be more effective than others. For example, metal ions can be used to stabilize proteins, while coenzymes can be used to catalyze reactions. The binding site is also important to consider when evaluating and analyzing cofactor binding (Aslanli, et al. 2019). Different binding sites can have different affinities for different cofactors, and some may be more effective than others.
Additionally, the binding site can affect the stability of the protein, as some binding sites may be more stable than others. The affinity of the binding is also important to consider when evaluating and analyzing cofactor binding. The affinity of the binding can affect the stability of the protein, as some binding sites may be more stable than others. Additionally, the affinity of the binding can affect the activity of the protein, as some binding sites may be more active than others. In spite of these the effect of the binding on the protein’s structure and function must be considered when evaluating and analyzing cofactor binding. The binding of a cofactor can affect the structure and function of the protein, and some binding sites may be more effective than others. Additionally, the binding of a cofactor can affect the stability of the protein, as some binding sites may be more stable than others. Overall, the evaluation and analysis of cofactor binding is a complex process that requires a thorough understanding of the structure and function of the protein and the cofactor. By considering the type of cofactor, the binding site, the affinity of the binding, and the effect of the binding on the protein’s structure and function, researchers can accurately evaluate and analyze cofactor binding.
Discussion
The production of recombinant proteins in a fermentor with a working capacity of 1000L requires careful consideration of the growth media, induction conditions, and other factors that can affect the yield and quality of the product. Furthermore, LB+ contains a higher concentration of glucose, which can be used as a carbon source for protein production. Therefore, LB+ is the preferred medium for this study. Once the growth media has been selected, the next step is to optimize the induction conditions. Isopropyl thio-β-D-galactopyranoside (IPTG) is the most commonly used inducer for protein production in E. coli. The optimal concentration of IPTG for protein production is depend on the strain of E. coli and the protein being produced. Generally, a concentration of 0.1 mM to 1 mM IPTG is sufficient for most proteins. However, it is important to test different concentrations of IPTG to determine the optimal concentration for the particular strain and protein being produced. In addition to the growth media and induction conditions, other factors must also be considered when optimizing the conditions for protein production (Zhou, et al. 2021). These include the temperature, pH, and oxygen levels in the fermentor. The optimal temperature for protein production is depend on the strain of E. coli and the protein being produced, but a temperature of 37°C is generally suitable for most proteins. The optimal pH for protein production is typically between 6.5 and 7.5, and the optimal oxygen level is between 20% and 30%. Finally, it is important to monitor the growth of the cells and the production of the protein throughout the fermentation process. This can be done by measuring the optical density of the culture and the concentration of the protein in the culture.
Monitoring the growth and production of the protein is allow for adjustments to be made to the growth media, induction conditions, and other factors as needed to optimize the conditions for protein production. In conclusion, the production of recombinant proteins in a 1000L fermentor requires careful consideration of the growth media, induction conditions, and other factors that can affect the yield and quality of the product. In this study, LB+ was selected as the growth media and IPTG was used as the inducer. The optimal concentration of IPTG, temperature, pH, and oxygen levels were determined, and the growth and production of the protein were monitored throughout the fermentation process. By optimizing the conditions for protein production, it is possible to achieve the highest yield of a high quality product. Protein production using a fermentor with a working capacity of 1000L is a significant process in the biotechnology industry. This process is used to produce large quantities of recombinant proteins, which are proteins that have been engineered to have specific characteristics. The use of a fermentor with a working capacity of 1000L allows for the production of large quantities of proteins in a relatively short amount of time. The production of proteins using a fermentor with a working capacity of 1000L is a significant process because it allows for the production of large quantities of proteins in a relatively short amount of time (Wei, et al. 2020). This process is especially important for the production of therapeutic proteins, which are proteins that are used to treat diseases or medical conditions. The production of therapeutic proteins requires large quantities of proteins in order to be effective, and the use of a fermentor with a working capacity of 1000L allows for the production of these large quantities in a relatively short amount of time. The production of proteins using a fermentor with a working capacity of 1000L is also significant because it allows for the production of proteins with specific characteristics. This process is especially important for the production of recombinant proteins, which are proteins that have been engineered to have specific characteristics. The use of a fermentor with a working capacity of 1000L allows for the production of large quantities of proteins with specific characteristics in a relatively short amount of time. The production of proteins using a fermentor with a working capacity of 1000L is also significant because it allows for the production of proteins using different media.
Production and purification of histidine tagged protein
There are several different methods that can be used to find tagged proteins in E. coli. Western blotting is an approach of determining whether an appropriate protein is commenced in a sample. This method uses an antibody specific for the protein of interest. Immunoprecipitation is a method of extracting specific proteins from a sample. This method uses an antibody specific for the protein of interest. An enzyme-linked immunosorbent assay (ELISA) is a method of determining whether a particular protein is present in a sample. This method uses an antibody specific for the protein of interest. “His tag” decontamination Benefits of “His-Tag” purification is a powerful tool for protein purification and offers several benefits. It is a simple and cost-effective method that can be used to purify proteins from a variety of sources, including cell lysates, tissue extracts, and recombinant expression systems (Zhou, et al. 2022). The His-Tag is a small peptide sequence that can be fused to the N- or C-terminus of a protein of interest, allowing it to be specifically recognized and bound by a metal-chelating resin. This method is highly efficient and can be used to purify proteins with high purity and yield. Additionally, His-Tag purification is fast and can be completed in a single step, making it ideal for high-throughput applications. Finally, His-Tag purification is compatible with a wide range of downstream applications, including enzymatic assays, structural studies, and protein-protein interactions.
The recombinant hexa histidine tagged enzyme is a type of enzyme that has been genetically engineered to contain six histidine residues at its N-terminal end. This enzyme is used in a variety of applications, including protein purification, protein detection, and protein-protein interactions. The hexa histidine tag is a peptide sequence that is composed of six histidine residues. This tag is used to facilitate the purification of proteins from a complex mixture. The tag binds to a metal ion, such as nickel, which can then be used to separate the tagged protein from the rest of the mixture. This allows for the purification of the desired protein from the mixture. The hexa histidine tag also allows for the detection of proteins in a sample. The tag can be used to create a specific antibody that can be used to detect the presence of the tagged protein in a sample. This is useful for a particular protein in this sample, such as in a diagnostic test. The hexa histidine tag can also be used to study protein-protein interactions
Accession of UniprotKB Q2ITX0 to identify the cloned enzyme
“UniprotKB Q2ITX0” is a protein sequence that corresponds to the enzyme Glutamate decarboxylase (GAD) from the bacterium Escherichia coli. GAD is an enzyme involved in the biosynthesis of the neurotransmitter “gamma-aminobutyric acid” (GABA). It catalyzes the decarboxylation of glutamate to GABA, using pyridoxal phosphate (PLP) as a cofactor. The mini-project of Production of a Recombinant Hexa Histidine Tagged Enzyme in E. coli involves the cloning and expression of GAD in E. coli. The enzyme is expressed as a recombinant protein with a hexa-histidine tag (6xHis) at the N-terminus. The 6xHis tag is a short peptide sequence of six histidine residues that can be used to purify the recombinant protein from the bacterial cell lysate. The first step in the mini-project is to clone the GAD gene from E. coli into a suitable expression vector. The vector should contain the 6xHis tag at the N-terminus of the GAD gene, as well as a promoter and a ribosome binding site for efficient expression of the protein. Once the vector is constructed, it can be transformed into E. coli cells and the expression of the recombinant GAD protein can be induced (Mohanty, et al. 2019). The next step is to purify the recombinant GAD protein from the bacterial cell lysate. This can be done using affinity chromatography, where the 6xHis tag is used to bind the protein to a column containing immobilized metal ions. The protein can then be eluted from the column using a buffer containing imidazole. Finally, the purified protein can be analyzed to confirm that it is the correct protein and that it is correctly folded. This can be done using SDS-PAGE and Western blotting. The protein can also be tested for its enzymatic activity, to ensure that it is able to catalyze the decarboxylation of glutamate to GABA. In conclusion, “UniprotKB Q2ITX0” corresponds to the enzyme Glutamate decarboxylase (GAD) from the bacterium Escherichia coli. This enzyme can be cloned and expressed as a recombinant protein with a hexa-histidine tag (6xHis) at the N-terminus in E. coli. The recombinant protein can then be purified and analyzed to confirm that it is correctly folded and has the correct enzymatic activity.
Recommendation to the executive committee for the prudence of a trial in the 1000L vessel
- Start with a small-scale trial: Before conducting a large-scale trial in a 1000L vessel, it is important to start with a small-scale trial in a smaller vessel. This will help to identify any potential issues that may arise during the larger-scale trial. It also help to determine the optimal conditions for the experiment, such as the temperature, pH, and other environmental factors (Maheshwari, et al. 2019). This will ensure that the larger-scale trial is conducted in the most efficient manner possible.
- Use a control group: It is important to use a control group when conducting a trial in a 1000L vessel. This will help to ensure that any changes in the protein yield are due to the experimental conditions and not due to any other factors. The control group should be kept under the same conditions as the experimental group, except for the variable being tested.
- Monitor the process: It is important to monitor the process throughout the trial. This helps to identify any potential issues that may arise during the experiment. It also helps to ensure that the conditions remain optimal for the experiment.
- Use a statistical analysis: It is important to use a statistical analysis to determine the significance of the results. This will help to ensure that the results are reliable and that any changes in the protein yield are due to the experimental conditions and not due to any other factors.
- Use a quality assurance system: It is important to use a quality assurance system to ensure that the experiment is conducted in the most efficient manner possible. This will help to ensure that the results are reliable and that any changes in the protein yield are due to the experimental conditions and not due to any other factors.
- Document the process: It is important to document the process throughout the trial. This will help to ensure that the results are reliable and that any changes in the protein yield are due to the experimental conditions and not due to any other factors.
- Use a risk assessment: It is important to use a risk assessment to identify any potential risks associated with the experiment. This must help to ensure that the experiment is conducted in the most efficient manner possible and that any changes in the protein yield are due to the experimental conditions and not due to any other factors. Overall, it is important to be prudent when conducting a trial in a 1000L vessel (Shmonova, et al. 2022). By following the above strategies, it is possible to ensure that the experiment is conducted in the most efficient manner possible and that any changes in the protein yield are due to the experimental conditions instead of depending upon any other factors.
Conclusion
The conclusion of this trial is that the use of a 1000L fermentor with recombinant E. coli BL21 (DE3) pET28-Q2ITX0 grown in LB and LB+ media and induced to produce protein with isopropyl thio-β-D-galactopyranoside is result in a high quality product with a good yield. The use of the LB and LB+ media provide the optimal environment for the bacteria to grow and produce the desired protein. The addition of isopropyl thio-β-D-galactopyranoside will induce the bacteria to produce the protein, resulting in a high quality product with a good yield. The use of a 1000L fermentor with recombinant E. coli BL21 (DE3) pET28-Q2ITX0 grown in LB and LB+ media and induced to produce protein with isopropyl thio-β-D-galactopyranoside is a cost-effective and efficient method for producing a high quality product with a good yield. By attaching the tag to one of the proteins in a complex, it can be used to study the interactions between the two proteins. The addition of isopropyl thio-β-D-galactopyranoside induces the bacteria to produce the protein, and are very much demanding for producing a demanding product. This can be used to gain insight into the structure and function of the proteins, as well as to identify potential drug targets. Overall, the recombinant hexa histidine tagged enzyme is a powerful tool for protein purification, detection, and protein-protein interactions. It is a valuable tool for researchers in a variety of fields, including biochemistry, molecular biology, and drug discovery the use of the LB and LB+ media provides the optimal environment for the bacteria to grow and produce the desired protein. The addition of isopropyl thio-β-D-galactopyranoside induces the bacteria to produce the protein. Overall, the use of a 1000L fermentor with recombinant E. coli BL21 (DE3) pET28-Q2ITX0 grown in LB and LB+ media and induced to produce protein with isopropyl thio-β-D-galactopyranoside is a reliable and cost-effective method for producing a high quality product with a good yield. The use of the LB and LB+ media provides the optimal environment for the bacteria to grow and produce the desired protein. This method is a reliable and cost-effective way to produce a high quality product with a good yield.
Reference list
Journal
Abd Elhameed, H.A., Hajdu, B., Balogh, R.K., Hermann, E., Hunyadi-Gulyás, É. and Gyurcsik, B., 2019. Purification of proteins with native terminal sequences using a Ni (II)-cleavable C-terminal hexahistidine affinity tag. Protein Expression and Purification, 159, pp.53-59.
Acheson, J.F., Ho, R., Goularte, N.F., Cegelski, L. and Zimmer, J., 2021. Molecular organization of the E. coli cellulose synthase macrocomplex. Nature Structural & Molecular Biology, 28(3), pp.310-318.
Akhtar, M.W., 2021. Translational Regulation of Recombinant Protein Expression in E. coli-A Review. PAKISTAN JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 54(3-4), pp.21-32.
Akhtar, M.W., 2021. Translational Regulation of Recombinant Protein Expression in E. coli-A Review. PAKISTAN JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 54(3-4), pp.21-32.
Aldosari, M.H., Rodriguez, L.R., Mastrobattista, E. and Schellekens, H., 2019. Transient expression of recombinant human acid sphingomyelinase in E. coli and CHO-K1 cells. Accessibility and Availability of Orphan Drugs: Challenges and Potential Solutions, p.105.
Aslanli, A.G., Stepanov, N.A., Senko, O.V., Maslova, O.V., Lyagin, I.V. and Efremenko, E.N., 2019, April. The hexahistidine containing organophosphorus hydrolase enzyme and bacterial cellulose based functional materials. In IOP Conference Series: Materials Science and Engineering (Vol. 525, No. 1, p. 012005). IOP Publishing.
Banu, M.S.A., Huda, K.M.K., Parveen, S., Robbani, M.G., Ahmed, B. and Harun-Ur-Rashid, M., ISOLATION, EXPRESSION AND PURIFICATION OF PEA ASCORBATE PEROXIDASE (PEA-APX) IN ESCHERICHIA COLI.
Darsana, D.K., 2021. Development of recombinant coat protein for immunodiagnosis of banana bunchy top and bract mosaic diseases (Doctoral dissertation, Department of Plant Pathology, College of Agriculture, Vellanikkara).
Dat, N.Q., Thuy, L.T.T., Hieu, V.N., Hai, H., Hoang, D.V., Thi Thanh Hai, N., Thuy, T.T.V., Komiya, T., Rombouts, K., Dong, M.P. and Hanh, N.V., 2021. Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology, 73(6), pp.2527-2545.
Dat, N.Q., Thuy, L.T.T., Hieu, V.N., Hai, H., Hoang, D.V., Thi Thanh Hai, N., Thuy, T.T.V., Komiya, T., Rombouts, K., Dong, M.P. and Hanh, N.V., 2021. Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology, 73(6), pp.2527-2545.
Daya, T., Jeje, O., Maake, R., Aloke, C., Khoza, T. and Achilonu, I., 2022. Expression, Purification, and Biophysical Characterization of Klebsiella Pneumoniae Nicotinate Nucleotide Adenylyltransferase. The Protein Journal, 41(1), pp.141-156.
De Vos, J., Aguilar, P.P., Köppl, C., Fischer, A., Grünwald-Gruber, C., Dürkop, M., Klausberger, M., Mairhofer, J., Striedner, G., Cserjan-Puschmann, M. and Jungbauer, A., 2021. Native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection for in-process control of SARS-CoV-2 nucleocapsid protein produced in Escherichia coli.
Duman-Özdamar, Z.E., Ünlü, A., Ünal, H., Woodley, J.M. and Bi̇nay, B., 2021. High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor. Protein Expression and Purification, 177, p.105753.
Eche, S. and Gordon, M.L., 2021. Recombinant expression of HIV-1 protease using soluble fusion tags in Escherichia coli: A vital tool for functional characterization of HIV-1 protease. Virus Research, 295, p.198289.
Esen, H., Alpdağtaş, S., Mervan Çakar, M. and Binay, B., 2019. Tailoring of recombinant FDH: effect of histidine tag location on solubility and catalytic properties of Chaetomium thermophilum formate dehydrogenase (CtFDH). Preparative Biochemistry & Biotechnology, 49(5), pp.529-534.
Ferreira, A.S., Lopacinski, A., Batista, M., Hiraiwa, P.M., Bueno, N.F., Guimarães, B.G. and Zanchin, N.I., 2022. Functional EGF domain of the human neuregulin 1α produced in Escherichia coli with accurate disulfide bonds. Molecular Biology Reports, 49(12), pp.11715-11727.
Flores, S.S., Clop, P.D., Barra, J.L., Argaraña, C., Perillo, M.A., Nolan, V. and Sanchez, J.M., 2020. Advantages and Disadvantages of His-Tagged Beta-Galactosidase.
Goloshchapova, K., Stehling, S., Heydeck, D., Blum, M. and Kuhn, H., 2019. Functional characterization of a novel arachidonic acid 12S‐lipoxygenase in the halotolerant bacterium Myxococcus fulvus exhibiting complex social living patterns. MicrobiologyOpen, 8(7), p.e00775.
Graeme, B., 2020. Elucidating the structure and improving the cellular uptake of HexM, a candidate for enzyme replacement therapy of GM2 gangliosidosis (Master’s thesis).
Hui, C.Y., Guo, Y., Liu, L., Zheng, H.Q., Wu, H.M., Zhang, L.Z. and Zhang, W., 2019. Development of a novel bacterial surface display system using truncated OmpT as an anchoring motif. Biotechnology letters, 41(6), pp.763-777.
Jia, L., Zhao, W., Wei, W., Guo, X., Wang, W., Wang, Y., Sang, J., Lu, F. and Liu, F., 2020. Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review. Critical reviews in biotechnology, 40(4), pp.475-489.
Kim, M. and Ryu, S.E., 2021. Purification, crystallization and X-ray crystallographic analysis of RPTPH. Biodesign, 9, pp.55-58.
Lingg, N., Cserjan‐Puschmann, M., Fischer, A., Engele, P., Kröß, C., Schneider, R., Brocard, C., Berkemeyer, M., Striedner, G. and Jungbauer, A., 2021. Advanced purification platform using circularly permuted caspase‐2 for affinity fusion‐tag removal to produce native fibroblast growth factor 2. Journal of Chemical Technology & Biotechnology, 96(6), pp.1515-1522.
Maheshwari, N., Kumar, M., Thakur, I.S. and Srivastava, S., 2019. Cloning, expression and characterization of β-and γ‑carbonic anhydrase from Bacillus sp. SS105 for biomimetic sequestration of CO2. International journal of biological macromolecules, 131, pp.445-452.
Mechri, S., Jaouadi, N.Z., Bouacem, K., Allala, F., Bouraoui, A., Ferard, C., Rekik, H., Noiriel, A., Abousalham, A., Bouanane-Darenfed, A. and Hacène, H., 2021. Cloning and heterologous expression of subtilisin SAPN, a serine alkaline protease from Melghiribacillus thermohalophilus Nari2AT in Escherichia coli and Pichia pastoris. Process Biochemistry, 105, pp.27-41.
Mohanty, N.N., Shivachandra, S.B., Biswas, S.K., Nagaraj, V., Basheer, T.J., Babu, D.N., Yogisharadhya, R. and Hemadri, D., 2019. An efficient production of hybrid recombinant protein comprising non-structural proteins (NS 1 & NS 3) of bluetongue virus in prokaryotic expression system. Protein Expression and Purification, 155, pp.15-20.
Mohanty, N.N., Shivachandra, S.B., Biswas, S.K., Nagaraj, V., Basheer, T.J., Babu, D.N., Yogisharadhya, R. and Hemadri, D., 2019. An efficient production of hybrid recombinant protein comprising non-structural proteins (NS 1 & NS 3) of bluetongue virus in prokaryotic expression system. Protein Expression and Purification, 155, pp.15-20.
Saxena, V.K., Vedamurthy, G.V. and Singh, R., 2021. Pyridoxal 5’-phosphate supplementation modulates the heterologous expression and activity of a PLP dependent model protein in E. coli. bioRxiv.
Shmonova, E.A., Savrasova, E.A., Fedorova, E.N. and Doroshenko, V.G., 2022. Comparative Analysis of Catabolic and Anabolic Dehydroshikimate Dehydratases for 3, 4-DHBA Production in Escherichia coli. Microorganisms, 10(7), p.1357.
Shmonova, E.A., Savrasova, E.A., Fedorova, E.N. and Doroshenko, V.G., 2022. Comparative Analysis of Catabolic and Anabolic Dehydroshikimate Dehydratases for 3, 4-DHBA Production in Escherichia coli. Microorganisms, 10(7), p.1357.
Soranzo, T., Ben Tahar, A., Chmayssem, A., Zelsmann, M., Vadgama, P., Lenormand, J.L., Cinquin, P., K. Martin, D. and Zebda, A., 2022. Electrochemical biosensing of glucose based on the enzymatic reduction of glucose. Sensors, 22(19), p.7105.
Soulari, R.N., Basafa, M., Rajabibazl, M. and Hashemi, A., 2020. Effective strategies to overcome the insolubility of recombinant ScFv antibody against EpCAM extracellular domain in E. coli. International Journal of Peptide Research and Therapeutics, 26(4), pp.2465-2474.
Strutton, B., Jaffe, S.R., Evans, C.A., Fowler, G.J., Dobson, P.D., Pandhal, J. and Wright, P.C., 2019. Engineering pathways in central carbon metabolism help to increase glycan production and improve N-type glycosylation of recombinant proteins in E. coli. Bioengineering, 6(1), p.27.
Sunil, L. and Vasu, P., 2020. Cloning and expression of in silico modeled protein enriched with branched chain amino acids in Pichia pastoris. International journal of biological macromolecules, 146, pp.739-745.
TRAN, T.H., THI, H.A.P., NGUYEN, M.N., NGUYEN, D.T. and KANG, L.W., 2020. CONSTRUCTING A NOVEL PLASMID TO INCREASE PURITY EFFECTIVENESS FOR RECOMBINANT PROTEINS EXPRESSED IN ESCHERICHIA COLI CELLS. Journal of Science and Technology-IUH, 44(02).
Tungekar, A.A., Castillo-Corujo, A. and Ruddock, L.W., 2021. So you want to express your protein in Escherichia coli?. Essays in Biochemistry, 65(2), pp.247-260.
Wang, K., Zhao, L., Li, T., Wang, Q., Ding, Z. and Dong, W., 2022. Selective Immobilization of His‐Tagged Phosphomannose Isomerase on Ni Chelated Nanoparticles with Good Reusability and Activity. ChemBioChem, 23(4), p.e202100497.
Wei, S.P., Qian, Z.G., Hu, C.F., Pan, F., Chen, M.T., Lee, S.Y. and Xia, X.X., 2020. Formation and functionalization of membraneless compartments in Escherichia coli. Nature chemical biology, 16(10), pp.1143-1148.
Wei, S.P., Qian, Z.G., Hu, C.F., Pan, F., Chen, M.T., Lee, S.Y. and Xia, X.X., 2020. Formation and functionalization of membraneless compartments in Escherichia coli. Nature chemical biology, 16(10), pp.1143-1148.
Wilson, R.H., Thieulin‐Pardo, G., Hartl, F.U. and Hayer‐Hartl, M., 2019. Improved recombinant expression and purification of functional plant Rubisco. FEBS letters, 593(6), pp.611-621.
Yu, X., Niks, D., Ge, X., Liu, H., Hille, R. and Mulchandani, A., 2019. Synthesis of formate from CO2 gas catalyzed by an O2-tolerant NAD-dependent formate dehydrogenase and glucose dehydrogenase. Biochemistry, 58(14), pp.1861-1868.
Yu, X., Niks, D., Ge, X., Liu, H., Hille, R. and Mulchandani, A., 2019. Synthesis of formate from CO2 gas catalyzed by an O2-tolerant NAD-dependent formate dehydrogenase and glucose dehydrogenase. Biochemistry, 58(14), pp.1861-1868.
Zhang, Y., Gao, H., Qi, X., Gao, S., Xu, S., Wang, H. and An, Y., 2021. Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia coli Vectors. Journal of Agricultural and Food Chemistry, 69(17), pp.5086-5095.
Zhang, Y., Gao, H., Qi, X., Gao, S., Xu, S., Wang, H. and An, Y., 2021. Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia coli Vectors. Journal of Agricultural and Food Chemistry, 69(17), pp.5086-5095.
Zhou, L.J., Li, R.F., Li, X.Y. and Zhang, Y.W., 2021. One‐step selective affinity purification and immobilization of His‐tagged enzyme by recyclable magnetic nanoparticles. Engineering in life sciences, 21(6), pp.364-373.
Zhou, Z., Zhao, H., Zhang, L., Xie, Q., Liu, Q., Tong, M., Yu, X. and Xiong, S., 2022. Soluble expression of bioactive recombinant porcine-human chimeric uricase mutant employing MBP-SUMO fusion system. Protein Expression and Purification, 189, p.105978.
Zhou, Z.R., Huang, W., Liu, K.J., Lin, F.L., Wang, X.L., Wang, F. and Jiang, R.W., 2021. Soluble expression, one-step purification and characterization of recombinant human growth hormone fused with ompA3 in Escherichia coli. Protein and Peptide Letters, 28(5), pp.533-542.
Know more about UniqueSubmission’s other writing services: